# Vytorin (10/20 Or 10/40) Compared to Atorvastatin (10 mg or 20 mg) in Patients With Coronary Artery Disease (0653A-126)(COMPLETED)

> **NCT00442897** · PHASE4 · COMPLETED · sponsor: **Organon and Co** · enrollment: 229 (actual)

## Conditions studied

- Hypercholesterolemia

## Interventions

- **DRUG:** simvastatin (+) ezetimibe
- **DRUG:** Comparator: atorvastatin

## Key facts

- **NCT ID:** NCT00442897
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09
- **Primary completion:** 2008-10
- **Final completion:** 2008-10
- **Target enrollment:** 229 (ACTUAL)
- **Last updated:** 2024-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00442897

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00442897, "Vytorin (10/20 Or 10/40) Compared to Atorvastatin (10 mg or 20 mg) in Patients With Coronary Artery Disease (0653A-126)(COMPLETED)". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00442897. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*